Bladder cancer Board decisions

The Board remands the service connection claims for coronary artery disease, bladder tumor, and peripheral neuropathy of both upper and lower extremities to correct duty to assist errors related to toxic exposure risk activities during active service.

The Board granted an earlier effective date of February 21, 2024, for the grant of service connection for bladder cancer but denied a compensable rating during the period on appeal.

The appeal for service connection for bladder cancer has been withdrawn by the Veteran.

The Board denied service connection for a bilateral ankle disorder, DMII, heart disorder, right shoulder disorder, hypertension, low back disorder, bladder cancer, and left and right lung disease as the weight of the evidence did not support a finding that any of these conditions were related to the Veteran's active duty service.

The Board remands the claims for service connection for an acquired psychiatric disability and increased evaluation for residuals, malignant neoplasm-in remission, voiding dysfunction due to a duty to assist error.

The Board denied the veteran's claims for increased ratings, eligibility for specially adaptive housing and a special home adaptation grant, and remanded several service connection claims.

The Board remands the claim for further development to verify whether the Veteran was exposed to herbicide agents during his service in Korea.

The Board remands the claims for service connection for bladder cancer, diabetes mellitus, type II, and prostate cancer due to a need for further development of evidence.

The appeal for service connection for ischemic heart disease and bladder cancer was dismissed as the appeals were not timely filed.

The Board denied a separate 100 percent rating for prostate cancer and special monthly compensation (SMC) at the housebound rate.

The Veteran's service-connected residuals of bladder cancer are granted a disability rating of 60 percent, effective October 1, 2021.

The Board granted a disability rating of 100 percent from July 1, 2023, to July 31, 2023, for service-connected bladder cancer residuals and denied a compensable disability rating from August 1, 2023.

The Board dismissed the appeal regarding a proposed reduction in the disability rating for bladder cancer and denied entitlement to a compensable disability rating for erectile dysfunction.

The Board remands the claims for a higher rating for residuals of bladder cancer and TDIU due to insufficient evidence.

The Board remands the claim for service connection for post-op bladder cancer with residuals to verify in-service asbestos exposure.

The Board granted service connection for a total hysterectomy secondary to service-connected bladder cancer and special monthly compensation based on loss of use of a creative organ, but remanded the claim for service connection for migraines.

The Board denied service connection for tinnitus, status post tumor resection for bladder cancer, heart disability, and an initial compensable rating for bilateral hearing loss. The claims were also remanded for further development.

The Veteran's claims for higher evaluations and earlier effective dates were granted.

The Board denied the Veteran's claim for a total disability rating based on individual unemployability (TDIU) as there was not sufficient evidence to show that his service-connected disabilities rendered him unable to secure and follow substantially gainful employment.

The Board remands the matter to obtain private treatment records and a retrospective opinion regarding the manifestations of the Veteran's bladder cancer residuals.